TARSUS PHARMACEUTICALS, INC. (TARS) /
The cash flow of TARSUS PHARMACEUTICALS, INC. over the past 8 years
Chart TARSUS PHARMACEUTICALS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2018–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, TARSUS PHARMACEUTICALS, INC.'s operating cash flow was -$12.45M and its capital expenditures $9.86M, leaving free cash flow of -$22.31M. Free cash flow was above zero in 1 of the 7 years shown. It ranged from -$119M in fiscal 2023 to $3.16M in fiscal 2021. Capital expenditures were highest in fiscal 2025, at $9.86M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$12.45M | $9.86M | -$22.31M |
| 2024ended Dec 31, 2024 | -$83.03M | $1.57M | -$84.59M |
| 2023ended Dec 31, 2023 | -$117.49M | $1.5M | -$119M |
| 2022ended Dec 31, 2022 | -$49.03M | $506K | -$49.54M |
| 2021ended Dec 31, 2021 | $3.75M | $586K | $3.16M |
| 2020ended Dec 31, 2020 | -$21.14M | $456K | -$21.59M |
| 2019ended Dec 31, 2019 | -$3.67M | $175K | -$3.85M |
| 2018 | — | — | — |
Fiscal years as TARSUS PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TARSUS PHARMACEUTICALS, INC.
- The revenue of TARSUS PHARMACEUTICALS, INC.
- The profitability of TARSUS PHARMACEUTICALS, INC.
- The debt of TARSUS PHARMACEUTICALS, INC.
- All of TARSUS PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTCTNETSCOUT SYSTEMS INC
- PRVAPrivia Health Group, Inc.
- BWINThe Baldwin Insurance Group, Inc.
- WSCWillscot Holdings Corporation
- EXTRExtreme Networks, Inc.
Not investment advice. This page shows what TARSUS PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.